New Potential Indications for Growth Hormone Therapy

ESPE Yearbook of Paediatric Endocrinology

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 22 | ESPEYB25

Yearbook of Paediatric Endocrinology 2025

4. Growth and Growth Factors

Previous section
Important for Clinical Practice

Table of contents

Next section
New Findings in Children with Prader-Willi Syndrome

ey0022.4-10 | New Potential Indications for Growth Hormone Therapy

4.10. A clinical trial of high-dose growth hormone in a patient with a dominant-negative growth hormone receptor mutation

ey0022.4-11 | New Potential Indications for Growth Hormone Therapy

4.11. Treatment of short stature in aggrecan-deficient patients with recombinant human GH: 3-year response

ey0022.4-12 | New Potential Indications for Growth Hormone Therapy

4.12. Clinical characteristics and response to growth hormone treatment in 27 children with heterozygous NPR2 variants: real-world data

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more